DocGo (DCGO) has released an update to notify the public and investors about a regulation fd disclosure.
The Company’s Board of Directors has approved a new share repurchase program, allowing for the buyback of up to $36 million of its common stock over a six-month period ending July 30, 2024. The repurchases can occur through various means such as open market transactions and Rule 10b5-1 trading plans, subject to market conditions and compliance with regulatory requirements. The program’s specifics, including the timing and number of shares to be repurchased, are flexible and the program may be altered or halted without notice. Funding for the buybacks will come from the Company’s cash reserves or financing options.
For further insights into DCGO stock, check out TipRanks’ Stock Analysis page.
For a comprehensive understanding of the announcement, you can read the full document here.
